11. Patients with plasma cell disorders undergoing autologous stem cell transplant retain their humoral response to COVID-19 vaccination but falling titers emphasize the importance of re-vaccination. Issue 10 (24th August 2022) Authors: Howells, Lara; Chan, Wei Yee; Sanchez, Emilie; Horder, Jacqueline; Newrick, Fiona; Marfil, Jotham; McMillan, Annabel; Wisniowski, Brendan; Mahmood, Shameem; Papanikolaou, Xenofon; Lee, Lydia; Wechalekar, Ashutosh; Popat, Rakesh; Sive, Jonathan; Kyriakou, Charalampia; Xu, Ke; Nastouli, Eleni; Yong... Journal: Leukemia & lymphoma Issue: Volume 63:Issue 10(2022) Page Start: 2489 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Rasch‐built overall disability scale for POEMS syndrome (POEMS‐RODS). Issue 4 (14th October 2022) Authors: Keh, Ryan Yann Shern; Lilleker, James B.; Lavin, Tim; Sive, Jonathan; D'Sa, Shirley; Ramdharry, Gita; Carr, Aisling S.; Lunn, Michael P. Journal: Journal of the peripheral nervous system Issue: Volume 27:Issue 4(2022) Page Start: 302 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy. (10th June 2020) Authors: Cook, Gordon; John Ashcroft, A; Pratt, Guy; Popat, Rakesh; Ramasamy, Karthik; Kaiser, Martin; Jenner, Matthew; Henshaw, Sarah; Hall, Rachel; Sive, Jonathan; Stern, Simon; Streetly, Matthew; Bygrave, Ceri; Soutar, Richard; Rabin, Neil; Jackson, Graham H Journal: British journal of haematology Issue: Volume 190:Number 2(2020) Page Start: e83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high‐risk myeloma patients – a single centre experience. (13th March 2021) Authors: Jurgensen‐Rauch, Amanda; Gibbs, Suzanne; Farrell, Maresa; Aries, James; Grantham, Marianne; Eccersley, Lydia; Gribben, John; Hallam, Simon; Oakervee, Heather; Cavenagh, Jamie; Davies, Jeff; Sive, Jonathan Journal: British journal of haematology Issue: Volume 193:Number 2(2021) Page Start: 420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial. Issue 11 (17th November 2022) Authors: Royle, Kara-Louise; Coulson, Amy Beth; Ramasamy, Karthik; Cairns, David A; Hockaday, Anna; Quezada, Sergio; Drayson, Mark; Kaiser, Martin; Owen, Roger; Auner, Holger W; Cook, Gordon; Meads, David; Olivier, Catherine; Barnard, Lorna; Lambkin, Rhiannon; Paterson, Andrea; Dawkins, Bryony; Chapman, M... Journal: BMJ open Issue: Volume 12:Issue 11(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Salvage second autologous stem cell transplant for relapsed multiple myeloma in the novel agent era benefits a subset of patients: single-center UK experience. Issue 14 (6th December 2021) Authors: Richards, Huw; Chavda, Selina J.; Wilson, William; Camilleri, Marquita; Cohen, Oliver; Horder, Jackie; Newrick, Fiona; Papanikolaou, Xenofon; Sive, Jonathan; Lee, Lydia; Popat, Rakesh; Wechalekar, Ashutosh; Kyriakou, Charalampia; Yong, Kwee; Rabin, Neil Journal: Leukemia & lymphoma Issue: Volume 62:Issue 14(2021) Page Start: 3544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV‐19 COVID‐19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors. (10th October 2021) Authors: Chan, Wei Yee; Howells, Lara; Wilson, William; Sanchez, Emilie; Ainley, Louise; Chavda, Selina J.; Dowling, Emma; Correia, Nuno; Lecat, Catherine S. Y.; McMillan, Annabel; Wisniowski, Brendan; Mahmood, Shameem; Papanikolaou, Xenofon; Lee, Lydia; Sive, Jonathan; Kyriakou, Charalampia; Wechalekar, ... Journal: British journal of haematology Issue: Volume 196:Number 3(2022) Page Start: e21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study. (1st March 2021) Authors: Camilleri, Marquita; Cuadrado, Maria; Phillips, Elizabeth; Wilson, William; Jenner, Richard; Pang, Gavin; Kamora, Sumaiya; Streetly, Matthew; Popat, Rakesh; Bygrave, Ceri; Owen, Roger; Cavenagh, James; Chapman, Mike; Sive, Jonathan; Eccersley, Lydia; Sheaff, Michael; Benjamin, Reuben; Ramasamy, K... Journal: British journal of haematology Issue: Volume 193:Number 4(2021) Page Start: 750 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib–cyclophosphamide–dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial. Issue 2 (February 2023) Authors: Yong, Kwee; Wilson, William; de Tute, Ruth M; Camilleri, Marquita; Ramasamy, Karthik; Streetly, Matthew; Sive, Jonathan; Bygrave, Ceri A; Benjamin, Reuben; Chapman, Michael; Chavda, Selina J; Phillips, Elizabeth H; del Mar Cuadrado, Maria; Pang, Gavin; Jenner, Richard; Dadaga, Tushhar; Kamora, Su... Journal: Lancet Issue: Volume 10:Issue 2(2023) Page Start: e93 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗